Daewoong Co., Ltd. (003090.KS)
KRW 20450.0
(0.74%)
KRW 20450.0
(0.74%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 93.41 Billion KRW | -55.58% |
| 2022 | 210.31 Billion KRW | 11.66% |
| 2021 | 188.36 Billion KRW | -36.3% |
| 2020 | 295.69 Billion KRW | 0.99% |
| 2019 | 292.81 Billion KRW | 62.96% |
| 2018 | 179.68 Billion KRW | -37.9% |
| 2017 | 289.33 Billion KRW | 0.06% |
| 2016 | 289.16 Billion KRW | 52.67% |
| 2015 | 189.41 Billion KRW | 35.77% |
| 2014 | 139.51 Billion KRW | 248.21% |
| 2013 | 40.06 Billion KRW | 1154.02% |
| 2012 | 3.19 Billion KRW | -71.12% |
| 2011 | 11.06 Billion KRW | -73.62% |
| 2010 | 41.93 Billion KRW | -20.1% |
| 2009 | 52.48 Billion KRW | -47.77% |
| 2008 | 100.5 Billion KRW | 218.0% |
| 2007 | 31.6 Billion KRW | 18865.44% |
| 2006 | 166.64 Million KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 93.41 Billion KRW | 43.72% |
| 2024 Q2 | 259.25 Billion KRW | 177.53% |
| 2023 Q3 | 52.37 Billion KRW | -63.74% |
| 2023 FY | 93.41 Billion KRW | -55.58% |
| 2023 Q1 | 208.95 Billion KRW | -0.65% |
| 2023 Q2 | 144.44 Billion KRW | -30.87% |
| 2023 Q4 | 93.41 Billion KRW | 78.35% |
| 2022 Q4 | 210.31 Billion KRW | -16.16% |
| 2022 Q1 | 188.93 Billion KRW | 0.31% |
| 2022 Q2 | 251.55 Billion KRW | 33.14% |
| 2022 FY | 210.31 Billion KRW | 11.66% |
| 2022 Q3 | 250.83 Billion KRW | -0.28% |
| 2021 Q2 | 197.17 Billion KRW | -33.44% |
| 2021 Q1 | 296.23 Billion KRW | 0.18% |
| 2021 Q3 | 290.27 Billion KRW | 47.22% |
| 2021 Q4 | 188.36 Billion KRW | -35.11% |
| 2021 FY | 188.36 Billion KRW | -36.3% |
| 2020 Q3 | 206.28 Billion KRW | -29.95% |
| 2020 FY | 295.69 Billion KRW | 0.99% |
| 2020 Q2 | 294.49 Billion KRW | 0.04% |
| 2020 Q1 | 294.37 Billion KRW | 0.53% |
| 2020 Q4 | 295.69 Billion KRW | 43.34% |
| 2019 Q1 | 181.88 Billion KRW | 1.22% |
| 2019 Q2 | 283.51 Billion KRW | 55.88% |
| 2019 Q4 | 292.81 Billion KRW | 3.4% |
| 2019 Q3 | 283.19 Billion KRW | -0.11% |
| 2019 FY | 292.81 Billion KRW | 62.96% |
| 2018 FY | 179.68 Billion KRW | -37.9% |
| 2018 Q4 | 179.68 Billion KRW | -35.67% |
| 2018 Q3 | 279.31 Billion KRW | 47.29% |
| 2018 Q2 | 189.63 Billion KRW | -34.48% |
| 2018 Q1 | 289.42 Billion KRW | 0.03% |
| 2017 FY | 289.33 Billion KRW | 0.06% |
| 2017 Q2 | 289.35 Billion KRW | 0.03% |
| 2017 Q3 | 199.54 Billion KRW | -31.04% |
| 2017 Q4 | 289.33 Billion KRW | 45.0% |
| 2017 Q1 | 289.25 Billion KRW | 0.03% |
| 2016 Q2 | 289.14 Billion KRW | 52.6% |
| 2016 Q4 | 289.16 Billion KRW | -0.03% |
| 2016 Q3 | 289.24 Billion KRW | 0.04% |
| 2016 FY | 289.16 Billion KRW | 52.67% |
| 2016 Q1 | 189.47 Billion KRW | 0.04% |
| 2015 Q4 | 189.41 Billion KRW | -20.85% |
| 2015 FY | 189.41 Billion KRW | 35.77% |
| 2015 Q1 | 139.55 Billion KRW | 0.03% |
| 2015 Q2 | 149.6 Billion KRW | 7.2% |
| 2015 Q3 | 239.29 Billion KRW | 59.95% |
| 2014 Q4 | 139.51 Billion KRW | 249.64% |
| 2014 Q3 | 39.9 Billion KRW | -0.47% |
| 2014 Q2 | 40.08 Billion KRW | 0.03% |
| 2014 FY | 139.51 Billion KRW | 248.21% |
| 2014 Q1 | 40.07 Billion KRW | 0.03% |
| 2013 Q1 | 2.42 Billion KRW | -24.1% |
| 2013 Q3 | 724.98 Million KRW | 0.0% |
| 2013 Q4 | 40.06 Billion KRW | 5426.48% |
| 2013 FY | 40.06 Billion KRW | 1154.02% |
| 2013 Q2 | 724.98 Million KRW | -70.1% |
| 2012 Q4 | 3.19 Billion KRW | 0.0% |
| 2012 FY | 3.19 Billion KRW | -71.12% |
| 2012 Q1 | - KRW | 0.0% |
| 2011 FY | 11.06 Billion KRW | -73.62% |
| 2011 Q1 | - KRW | 0.0% |
| 2011 Q3 | -7.92 Billion KRW | 0.0% |
| 2011 Q2 | - KRW | 0.0% |
| 2010 FY | 41.93 Billion KRW | -20.1% |
| 2010 Q2 | - KRW | 0.0% |
| 2010 Q3 | - KRW | 0.0% |
| 2009 Q2 | - KRW | 0.0% |
| 2009 Q3 | - KRW | 0.0% |
| 2009 Q4 | - KRW | 0.0% |
| 2009 FY | 52.48 Billion KRW | -47.77% |
| 2008 Q2 | - KRW | 0.0% |
| 2008 Q4 | - KRW | 0.0% |
| 2008 Q3 | - KRW | 0.0% |
| 2008 FY | 100.5 Billion KRW | 218.0% |
| 2007 Q4 | - KRW | 0.0% |
| 2007 Q2 | - KRW | 0.0% |
| 2007 FY | 31.6 Billion KRW | 18865.44% |
| 2007 Q3 | - KRW | 0.0% |
| 2006 FY | 166.64 Million KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PharmGen Science, Inc. | 532.33 Million KRW | -17448.186% |
| Wooridul Huebrain Limited | 213.88 Million KRW | -43575.486% |